Cassava Sciences Inc vs Snowflake Inc — how do they compare? Cassava Sciences Inc trades at $0.97 (market cap $47.75M), while Snowflake Inc trades at $333 (market cap $116.01B). The key difference: Snowflake Inc is far larger — about 2429.5× Cassava Sciences Inc's market cap, and Snowflake Inc is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.
| FLNA | SNOW | |
|---|---|---|
Market Cap | $47.75M | $116.01B |
Sector | Health | Technology |
52-Week High | $4.64 | $334.70 |
52-Week Low | $0.87 | $121.11 |
Enterprise Value | -$34.93M | $115.82B |
Trailing returns across standard periods
Latest headlines on both assets
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →Founded in 2012, Snowflake is a data lake, warehousing, and sharing company that came public in 2020. To date, the company has over 3,000 customers including nearly 30% of the Fortune 500 as its customers. Snowflake's data lake stores unstructured and semistructured data that can then be used in analytics to create insights stored in its data warehouse. Snowflake's data sharing capability allows enterprises to easily buy and ingest data almost instantaneously compared with a traditionally months-long process. Overall, the company is known for the fact that all of its data solutions that can be hosted on various public clouds.
Read more on SNOW →